Feline immunodeficiency virus infection—a model for HIV and AIDS?

References

1. Pedersen N. C., Ho E. W., Brown M. L., Yamamoto J. K. Isolation of T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987; 235:790–793
   [Google Scholar]
2. Hopper C. D., Sparkes A. H., Harbour D. A. Feline immune-deficiency virus. In Chandler E. A., Gaskell C. J., Gaskell R. M. (eds) Feline medicine and therapeutics 2nd edn Oxford: Blackwell Scientific Publications; 1994488
   [Google Scholar]
3. Bennett M., Smyth N. R. Feline immunodeficiency virus: a brief review. Br Vet J 1992; 148:399–412
   [Google Scholar]
4. Barr M. C., Calle P. P., Roelke M. E., Scott F. W. Feline immune-deficiency virus infection in non-domestic felids. J Zool Wildl Med 1989; 20:265–272
   [Google Scholar]
5. Brown E. W., Miththapala S., O’Brien S. J. Prevalence of exposure to feline immunodeficiency virus in exotic felid species. J Zool Wildl Med 1993; 24:357–364
   [Google Scholar]
6. Elder J. H., Phillips T. R. Molecular properties of feline immune-deficiency virus (FIV). Infect Ag Dis 1993; 2:361–374
   [Google Scholar]
7. Miyazawa T., Tomonaga K., Kawaguchi Y., Mikami T. The genome of feline immunodeficiency virus. Arch Virol 1994; 134:221–234
   [Google Scholar]
8. Sodora D. L., Shpaer E. G., Kitchell B. E., Dow S. W., Hoover E. A., Mullins J. I. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol 1994; 68:2230–2238
   [Google Scholar]
9. Elder J. H., Lerner D. L., Hasselkus-Light C. S Distinct subsets of retroviruses encode dUTPase. J Virol 1992; 66:1791–1794
   [Google Scholar]
10. Kiyomasu T., Miyazawa T., Furuya T. Identification of feline immunodeficiency virus rev gene activity. J Virol 1991; 65:4539–4542
    [Google Scholar]
11. Phillips T. R., Lamont C., Konings D. A Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol 1992; 66:5464–5471
    [Google Scholar]
12. Rigby M. A., Holmes E. C., Pistello M., Mackay A., Leigh Brown A. J., Neil J. C. Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol 1993; 74:425–436
    [Google Scholar]
13. Pancino G., Fossati I., Chappey C. Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 1993; 192:659–662
    [Google Scholar]
14. Pancino G., Chappey C., Saurin W., Sonigo P. B epitopes and selection pressures, in feline immunodeficiency virus envelope glycoproteins. J Virol 1993; 67:664–672
    [Google Scholar]
15. Siebelink K. H. J., Rimmelzwaan G. F., Bosch M. L., Meloen R. H., Osterhaus A. D. M. E. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J Virol 1993; 67:2202–2208
    [Google Scholar]
16. Lombardi S., Garzelli C., La Rosa C. Identification of a linear neutralization site within the 3rd variable region of the feline immunodeficiency virus envelope. J Virol 1993; 67:4742–4749
    [Google Scholar]
17. Sellon R. K., Jordan H. L., Kennedy-Stoskopf S., Tompkins M. B., Tompkins W. H. Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol 1994; 68:3380–3385
    [Google Scholar]
18. Bishop S. A., Whiting C. V., Gruffydd-Jones T. J., Harbour D. A., Stokes C. R. Aspects of mucosal immunopathogenesis with FIV. Abstract in Medical Research Council 7th Annual AIDS Workshop; Brighton: 1993
    [Google Scholar]
19. George J. W., Pedersen N. C., Higgins J. The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res Hum Retroviruses 1993; 9:897–905
    [Google Scholar]
20. Brown W. C., Bissey L., Logan K. S., Pedersen N. C., Elder J. H., Collisson E. W. Feline immunodeficiency virus infects both CD4⁺ and CD8⁺ T lymphocytes. J Virol 1991; 65:3359–3364
    [Google Scholar]
21. Brunner D., Pedersen N. C. Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol 1989; 63:5483–5488
    [Google Scholar]
22. Dow S. W., Poss M. L., Hoover E. A. Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr 1990; 3:658–668
    [Google Scholar]
23. Norimine J., Miyazawa T., Kawaguchi Y. Feline CD4 molecules expressed on feline non-lymphoid cell-lines are not enough for productive infection of highly lymphotropic feline immunodeficiency virus isolates. Arch Virol 1993; 130:171–178
    [Google Scholar]
24. Willett B. J., Hosie M. J., Jarrett O., Neil J. C. Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homolog of CD9. Immunology 1994; 81:228–233
    [Google Scholar]
25. English R. V., Johnson C. M., Gebhart D. H., Tompkins M. B. In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol 1993; 67:5175–5186
    [Google Scholar]
26. Beebe A. M., Dua N., Faith T. G., Moore P. F., Pedersen N. C., Dandekar S. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets. J Virol 1994; 68:3080–3091
    [Google Scholar]
27. Willett B. J., Hosie M. J., Callanan J. J., Neil J. C., Jarrett O. Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8⁺ lymphocyte subset. Immunology 1993; 78:1–6
    [Google Scholar]
28. Pantaleo G., Demarest J. F., Soudeyns H. Major expansion of CD8⁺ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994; 370:463–467
    [Google Scholar]
29. Shelton G. H., Grant C. K., Cotter S. M., Gardner M. B., Hardy W. D., DiaGiacomo R. F. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: a retrospective study (1968–88). J Acquir Immune Defic Syndr 1990; 3:623–630
    [Google Scholar]
30. Thomas J. B., Robinson W. F., Chadwick B. J., Robertson I. D., Beetson S. A. Association of renal-disease indicators with feline immunodeficiency virus infection. J Am Anim Hosp Assoc 1993; 29:320–326
    [Google Scholar]
31. English R. V., Davidson M. G., Naisse M. P., Jamieson V. E., Lapin M. R. Intraocular disease associated with feline immunodeficiency virus infection in cats. J Am Vet Med Assoc 1990; 196:1116–1119
    [Google Scholar]
32. North T. W., North G. L. T., Pedersen N. C. Feline immune-deficiency virus, a model for reverse transcriptase-targeted chemotherapy for acquired immune deficiency syndrome. Antimicrob Agents Chemother 1989; 33:915–919
    [Google Scholar]
33. Egberink H., Borst M., Niphuis H. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phospho-nomethoxyethyl) adenine. Proc Natl Acad Sci USA 1990; 87:3087–3091
    [Google Scholar]
34. Cronn R. C., Remington K. M., Preston B. D., North T. W. Inhibition of reverse transcriptase from feline immunodeficiency virus by analogs of 2′deoxyadenosine-5′-triphosphate. Biochem Pharmacol 1992; 44:1375–1381
    [Google Scholar]
35. Smyth N. R., McCracken C. M., Gaskell R. M Susceptibility in cell culture of feline immunodeficiency virus to eighteen compounds. J Antimicrob Chemother 1994; 34:589–594
    [Google Scholar]
36. Tanabe-Tochikura A., Tochikura T. S., Blakeslee J. R., Olsen R. G., Mathes L. E. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FlV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro. Antiviral Res 1992; 19:161–172
    [Google Scholar]
37. Hartmann K., Donath A., Beer B. Use of two virustatica (AZT, PMEA) in the treatment of FIV and FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol 1992; 35:167–175
    [Google Scholar]
38. Smyth N. R., Bennett M., Gaskell R. M., Brown A., Gaskell C. J. Treatment for FIV?. Vet Rec 1990; 126:409–410
    [Google Scholar]
39. Hayes K. A., Lafrado L. J., Erickson J. G., Marr J. M., Mathes L. E. Prophylactic ZDV therapy prevents early viraemia and lymphocyte decline but not primary infection in feline immunodeficiency virus inoculated cats. J Acquir Immune Defic Syndr 1993; 6:127–134
    [Google Scholar]
40. Meers J., del Fierro G. M., Cope R. B., Park H. S., Greene W. K., Robinson W. F. Feline immunodeficiency virus infection: plasma but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine. Arch Virol 1993; 132:67–81
    [Google Scholar]
41. Smyth N. R., Bennett M., Gaskell R. M., McCracken C. M., Hart C. A., Howe J. L. Effect of 3′azido–2′, 3′–deoxythymidine on experimental feline immunodeficiency virus infection of domestic cats. Res Vet Sci 1994; 57:220–224
    [Google Scholar]
42. Hosie M. J., Osborne R., Reid G., Neil J. C., Jarrett O. Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol 1992; 35:191–197
    [Google Scholar]
43. Hosie M. J. The development of a vaccine against feline immunodeficiency virus. Br Vet J 1994; 150:25–39
    [Google Scholar]
44. Johnson C. M., Torres B. A., Koyama H., Yamamoto J. K. FIV as a model for AIDS vaccination. AIDS Res Hum Retroviruses 1994; 10:225–228
    [Google Scholar]
45. Hohdatsu T., Pu R., Torres B. A., Trujillo S., Gardner M. B., Yamamoto J. K. Passive antibody protection of cats against feline immunodeficiency virus infection. J Virol 1993; 67:2344–2348
    [Google Scholar]
46. Callanan J. J., Hosie M. J., Jarrett O. Transmission of feline immunodeficiency virus from mother to kitten. Vet Rec 1991; 128:332–333
    [Google Scholar]